Kevin Kavanagh, MD

Information presented at this week's Congressional Committee needs a much deeper evaluation and consideration. The Cochrane Masking study may even vindicate the federal government's initial COVID-19 response.

Specifically for older individuals and immunocompromised individuals, a year could be too long.

Post-COVID-19 immune dysfunction is supported by epidemiological, clinical, and laboratory evidence. Attributing, with little to no evidence, that masking and lack of exposure is the primary driver of increases in bacterial and viral infections discourages critical interventions needed to stop the spread of disease.

Catching COVID-19 to prevent a more severe case is not a good strategy, says Kevin Kavanagh, MD.

The FDA's Vaccines and Related Biological Products Advisory Committee laid out a simpler direction for SARS-CoV-2 development and deployment.

Kevin Kavanagh, MD, examines the current bird flu outbreak and the possible dangers it holds for humans.

Kevin Kavanagh, MD, explains his concern about immunodysfunction and the possibility of its effects on hospitals.

Kevin Kavanagh, MD, discusses the continued concerns about COVID-19 vaccine efficacy reduction and what he believes should be done to protect against the further spread.

A study from Canada suggests that not being vaccinated for COVID-19 could mean an individual is at higher risk for an automobile accident. What if it is from brain damage from contracting COVID-19?

With many of the new COVID-19 vaccines not as effective against the new variants, reducing their spread without pharmaceuticals is even more critical.

Kevin Kavanagh, MD, reviews a book examining the results of Sweden's controversial decisions made during the early COVID-19 pandemic.

As the festive holidays begin, even with vaccinations and boosters, COVID-19 still remains a concern for long COVID-19 and other severe long-term effects.

CDC discusses potential proposals to redefine spread and to produce uniform guidelines across different types of facilities because public health interventions do not cause immunological debt but instead may prevent immunocompromising infections.

Despite study results that the univalent BA.5 booster produced much higher increase in antibodies, why was the hybrid bivalent Ancestral/BA.5 booster with a significantly lower increase chosen to be distributed, and how does this put the population at risk?

The additive effects of long COVID-19 with repeat infections, combined with the long-term persistence of long COVID-19 systems, does not bode well for the United States’ workforce. N95 masks, vaccines, boosters, and improvements in ventilation are keys to prevention.

Starting September first, the first of the autumn boosters began to be available, but individuals may be concerned about their efficacy and safety. Infection Control Today® looks at the data.

Last week the Centers for Disease Control and Prevention relaxed recommendations which neither control or prevent a rapidly evolving and disabling disease, COVID-19. However, we must maintain effective efforts to control spread of the virus.

It is apparent we cannot simply vaccinate our way back to normal. We must also encourage the public to adopt public health strategies, including the wearing of N95 masks, avoiding close contact with strangers, and improved indoor ventilation. Now, more than ever, infection preventionists are needed to turn this tide around.

With the World Health Organization declaring monkeypox a global emergency, Infection Control Today® looks at what lessons SARS-CoV-2 gave but were not followed, and what could be next.

It is easy to become complacent, but the SARS-CoV-2 pandemic is not over, and long COVID-19 and the new variants are causing rising concern.

Disinformation is continuing, even in the face of staggering evidence that COVID-19 is an ongoing dangerous pandemic.

With more confirmed cases in the United States, and the CDC raising the travel alert to Level 2, should individuals be concerned? ICT investigates.

The bugs are winning, but only because we are letting them.

Few individuals in the United States are currently wearing masks, and many are continuing to engage in risky behavior. This may well be a toxic mix, and healthcare facilities and infection preventionists need to prepare for another possible surge in cases.   

Evidence shows the BA.2 variant is more infectious and virulent than the Omicron variant.

Other nations, such as Sweden and Australia, outperformed the US metrics.

Multiple studies and reports show that masks in schools are effective, safe, and necessary because COVID-19 is not going away.

A new study supports the conclusion that the “brain fog” reported by many who have recovered from mild COVID-19 infection is real and has an anatomical basis.

The virus may have found yet another stable host in the white-tailed deer population.

Dr. Kevin Kavanagh shares his perspective on the new CDC mask guidance.